General Information of the Compound
| Compound ID |
CP0845805
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-5-chloro-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H39ClF2N8O2
|
||||||||||||||||||
| Molecular Weight |
749.266
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(N3CCCCC3)CC2)c(Cl)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H39ClF2N8O2/c1-54-35-25-34(51-21-15-28(16-22-51)50-18-4-2-5-19-50)29(42)24-33(35)47-41-45-17-14-32(46-41)39-37(48-36-13-3-6-20-52(36)39)26-9-7-10-27(23-26)40(53)49-38-30(43)11-8-12-31(38)44/h3,6-14,17,20,23-25,28H,2,4-5,15-16,18-19,21-22H2,1H3,(H,49,53)(H,45,46,47)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SOWGILYZZBBQMD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor